Heart Failure

30-Day Home Time Performance as a Hospital Quality Metric for Patients With Heart Failure

October 30th 2020, 8:57pm


The novel patient-centered performance metric was associated with readmission and mortality outcomes, as well as reclassification of hospital performance, compared with a CMS 30-day metric.

Sacubitril/Valsartan Treatment for HFrEF Results in Removal of Prior Authorization Requirement

October 28th 2020, 4:42pm


Study results demonstrate the multimillion-dollar savings achieved among patients with heart failure with reduced ejection fraction (HFrEF) following treatment initiation with sacubitril and valsartan.

Sacubitril/Valsartan Has Possible Economic Benefit When Administered in a Hospital Setting to Patients With HFrEF

October 23rd 2020, 5:18pm


Heart failure with reduced ejection fraction (HFrEF) is when the heart’s left ventricle can only pump out 40% or less of the blood it contains, resulting in less oxygen-rich blood being disseminated to the body than it actually needs.

SGLT2 Inhibitors Shine as Therapy for Patients With Heart Failure

October 20th 2020, 10:30pm


A recent review in Current Diabetes Reports delves into the utility of sodium-glucose co-transporter-2 (SGLT2) inhibitors for patients with heart failure currently on other medications.

Prognosis Poor for Patients With Heart Failure, COVID-19

October 16th 2020, 6:03pm


Patients with heart failure should be classified as high risk in light of the coronavirus disease 2019 (COVID-19) pandemic; they are thought to be more susceptible to the virus.

QOL Negatively Impacted by Non–Cardiovascular-Related Comorbidities Among Patients With Chronic Heart Failure

October 14th 2020, 9:26pm


Patients with chronic heart failure and comorbid mental/behavioral disorders or diabetes had worse quality of life (QOL), according to a recent literature review.

Does Cardiogenic Shock Affect Mortality, Heart Failure Risks Among First-time MI Survivors?

October 9th 2020, 6:45pm


At the 1-year mark, following their first myocardial infarction (MI, or heart attack), heart failure hospitalizations and all-cause mortality were higher among patients who also had cardiogenic shock vs those who did not.

How Do Hospitalizations for Heart Failure Differ Before vs During the COVID-19 Era?

October 7th 2020, 9:15pm


Patients hospitalized for acute heart failure during the coronavirus disease 2019 (COVID-19) pandemic had more advanced disease and were more symptomatic, according to study results out of Australia.

Patients, Health Care Providers Prioritize Heart Failure Education Differently

October 2nd 2020, 6:30pm


The results of a recent study out of South Korea show that diet management education appeared more important to health care providers than it did their patients, while both expressed the significance of medication knowledge.

Infection With SARS-CoV-2 May Predispose Patients to HFpEF

October 1st 2020, 1:20pm


Patients testing positive for severe acute respiratory syndrome (SARS-CoV-2), the virus that causes coronavirus disease 2019, are presenting more often with signs of heart failure with preserved ejection fraction (HFpEF).